When people think about vape ingredient safety, the conversation usually turns to contaminants: pesticides, leftover solvents and heavy metals. Those matter. But according to toxicologist Shawna Vreeke, they‘re only part of the picture.

“Contaminants and impurities are unintentional, but that doesn’t mean that we can ignore intentionally added ingredients,” says Vreeke, director of toxicology at True Terpenes. “Those can cause just as much harm.”

That idea drives the vape ingredient safety program the Portland, Oregon-based terpene company launched in 2020, long before most of the cannabis industry was thinking about the toxicology of flavor and aroma ingredients. True Terpenes, whose formulations end up in more than $8 billion worth of cannabis and hemp products sold each year across 107 countries, recently completed the program‘s first independent review by an outside board-certified toxicologist, a check it plans to repeat annually.

Building It Anyway

Portrait of Daniel Cook, a smiling man with a shaved head and graying beard, wearing a tan jacket over a navy button-up shirt against a light gray background.
True Terpenes CEO Daniel Cook.

Daniel Cook, CEO of True Terpenes, joined the company full-time in early 2020. That same year, True Terpenes hired Vreeke to design and lead its toxicology program.

Cook says no single event set the program in motion. Instead, it fits a long-standing pattern: the company has “always invested way ahead of the market and way ahead of regulations when it wasn‘t required,“ he says.

That approach runs against what he calls a short-term, transactional mindset that can take hold in a young industry. “We’re not in this to flip the company or get in, get out,” Cook says. “We want to be a part of a long-term sustainable industry, and we want to have a company that’s going to be around for decades.” As he put it in the company‘s announcement, “We built it because an industry that asks for trust has to earn it first.“

The commitment came with real tradeoffs. Clients weren’t asking for a toxicology program in 2020, and the limits it set made product development harder. “It takes longer to find innovative ways to deliver the experience, the flavor, the aroma that you’re looking for, because you’re painting with a limited palette,” Cook says.

Vreeke arrived with her own reasons for caring about what goes into a vape. She earned her doctorate at Portland State University studying nicotine vaping and defended her dissertation at the end of 2019, just after the EVALI outbreak, a wave of lung injuries linked to vaping products. That crisis, she says, “really helped shed light on the idea that maybe not everything is safe to inhale and manufacturers should be thinking about what they’re putting in their products.”

Her skepticism started earlier. She remembers when e-cigarettes first came out and their vapor was described as harmless water. “I had a bachelor’s in chemistry, so I understood enough about materials to be like, there’s no way that’s water,” she says.

How the Program Works

Under True Terpenes’ approach to vape ingredient safety, every ingredient that goes into a vape formulation gets its own risk assessment. Vreeke starts by gathering all the data she can find on a compound, from peer-reviewed journals to existing regulatory limits, and weighs it together to understand the ingredient’s hazards.

Some ingredients are ruled out at that stage. “If it’s carcinogenic and it causes cancer, we’re not gonna put it in a product,” Vreeke says. The same goes for ingredients that research shows break down at vape temperatures into compounds that cause cancer even at very low levels.

For everything else, she picks the single best study available, ideally one as close as possible to a person inhaling the compound. She then scales that result to human inhalation and typical cannabis consumer use. The result is a daily usage limit for each ingredient, and the product team has to formulate under it.

When good data doesn’t exist, Vreeke relies on established toxicology methods. If a compound occurs naturally in cannabis, she can cap it at the levels found in the plant. For a novel compound, she can borrow data from a closely related substance or apply conservative default thresholds developed by toxicologists for chemicals with limited data.

Those limits are proprietary, so True Terpenes doesn’t share them with brand clients. Instead, it tells clients what concentration to use each blend at so their products stay within the program’s limits.

A Second Set of Eyes

A lab worker in a hairnet, safety glasses, black gloves and a blue True Terpenes lab coat uses a dropper to add liquid to a small blue bottle on a lab scale, with analytical equipment in the background.
A True Terpenes formulator measures ingredients in the company’s lab.

After running its vape ingredient safety program for several years, True Terpenes brought in an outside toxicologist to examine it. The reviewer holds a doctorate in pharmacology and is board-certified by the American Board of Toxicology. She has completed more than 200 toxicological evaluations of ingredients in e-liquids and cannabis distillates and has led nonclinical toxicology work for U.S. Food and Drug Administration applications for tobacco products.

Cook compares the review to a growing company hiring an accountant to check its books. “With growth companies, they’ll do their own financials for a while, and then at some point they’ll call in a CPA to audit their financials,” he says.

The review looked at the program’s methodology and the procedures used to carry it out. Cook says a main outcome was stronger standard operating procedures that shape how decisions are made across the company, not only by Vreeke. 

“It’s also a good signal to our clients,” Cook adds, “that we’re willing to put our work out there and have people check it.”

For Vreeke, the review brought both validation and a new resource. “It’s more buy-in, it’s more credibility,” she says. “I have more support now. I can reach out to that toxicologist if I have questions or concerns.”

From One Company’s Method to an International Standard

The company’s approach to vape ingredient safety now reaches well beyond True Terpenes. Vreeke worked with other toxicologists and a university professor to publish the risk assessment methodology in a peer-reviewed journal. ASTM International, a nonprofit that develops voluntary technical standards, then reached out about turning it into a standard.

The result was two standards from ASTM’s Committee D37 on Cannabis, with Vreeke serving as technical writer and key contact. ASTM D8587 helps manufacturers choose the toxicological data to base an assessment on for a non-cannabinoid ingredient that will be vaporized. ASTM D8588 lays out how to calculate how much of that ingredient a person can inhale each day.

To be published, the standards had to clear every negative vote from the committee, either by persuading members or by revising the text. “So that really shows the strength of that methodology,” Vreeke says. Cook calls the standards “an honor” and recognition of years of investment in the program.

The standards also say outright that they don’t declare any ingredient or product safe to inhale. Vreeke pushed for that language because, in toxicology, nothing is risk-free. “It’s the dose that makes it a poison,” she says, pointing to one of the field’s best-known principles.

Rather than calling a product safe, she prefers terms like “reduced risk” and “negligible harm.” “If there are adverse reactions, they may be as insignificant as a cough,” she says.

Where Vape Ingredient Safety Falls Short

Portrait of Shawna Vreeke, a smiling woman with long curly hair, wearing a navy True Terpenes jacket in front of a lab.
Shawna Vreeke, director of toxicology at True Terpenes.

Vreeke says regulators have largely fallen short on intentionally added ingredients. Some don’t regulate them at all, some ban them outright, and others lean on broad labels like “all natural.” But a label like that says nothing about safety. “Natural does not equal safe,“ she says. “I’m sure you can think of five natural things right now that are extremely toxic.”

She sees a practical alternative. Regulators could require ingredient makers to perform documented risk assessments and then spot-check them. “It should be really easy for regulators to just come in and randomly pick a compound and say, show me your risk assessment on this compound,” she says.

Hardware is another blind spot. “There is no regulation around hardware,” Vreeke says. A device that runs too hot can break ingredients down into harmful byproducts. And because most states test cannabis extract before it goes into a device, they generally aren‘t checking whether the hardware itself releases heavy metals or other contaminants.

Cook acknowledges regulators face a tough task in a highly technical field. He encourages them to work with companies that have this expertise to build sensible rules that put public safety first. Vreeke makes the same offer directly: “I am willing to collaborate and work with regulators to help write sensible regulations that are based on science and actually protect the consumer health.”

Accountability Shouldn’t Fall on Consumers

When it comes to vape ingredient safety, Vreeke’s advice for brands is simple: ask your terpene supplier whether it performs risk assessments, and how. Brands can use the ASTM standards and the published methodology to guide those questions.

They should also ask what concentration to use a blend at. “Even if a terpene supplier is performing a toxicology risk assessment, if a manufacturer goes and adds that product in at 15, 20%, then they’re probably outside of the range of the risk assessment,” she says.

What she won’t do is put the burden on shoppers. “The consumer should be able to go into a legal store and trust the product they’re buying,” Vreeke says. “Manufacturers need to own that responsibility, and regulators need to own that responsibility of confirming that manufacturers are doing the right thing.”

Both Cook and Vreeke say they want more companies doing this work, not fewer. “We don’t need to be the only program,” Cook says. “The more groups that are doing this, the better.” Vreeke says she’s already hearing that other terpene suppliers are reaching out to toxicologists. “We want to see the whole industry rise up,” she says.

Next Stop: MJBizCon

Five amber bottles of True Terpenes Headstash full-spectrum live extract, labeled Haze, Kush, Sour Diesel, Gelato and Purp, each against a different colored background.
True Terpenes’ Headstash line will be among the products showcased at MJBizCon.

True Terpenes will be at MJBizCon again this year, as it has been every year Cook has been with the company. Rather than exhibiting on the show floor, the company is sponsoring several events, including The Aroma Hour, where press will get a first look at its 2027 Trend Report, and the LOUD Omakase Culinary & Cannabis Experience, a tasting that pairs caviar with True Terpenes aromatics.It will also showcase 30 new LOUD Flavors, its Headstash line and two new Cultivar Series strains, Durban Poison and Trainwreck, with Durban Poison’s release marking the company’s 10th anniversary.

Cook calls the show a key moment to connect with clients and plan the year ahead. “The timing is always early December, so looking forward to the next year is always a big theme,” he says. Conversations will center on product innovation and roadmaps, but he expects the independent review to come up.

“There’s the confidence and the assurance that in the background the toxicology program is always there,” he adds.

The post What‘s Really in Your Vape? True Terpenes Puts Its Safety Program to the Test appeared first on Cannabis Now.



Read More: What‘s Really in Your Vape? True Terpenes Puts Its Safety Program to the Test

Comments are closed, but trackbacks and pingbacks are open.